Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNAPTICS Inc Director's Dealing 2015

Nov 5, 2015

31479_dirs_2015-11-04_a3f3c285-782c-4764-ab88-30ea0e89788d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNAPTICS Inc (SYNA)
CIK: 0000817720
Period of Report: 2015-11-02

Reporting Person: Deutsch Scott (SVP of Worldwide Sales)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-02 Common Stock M 1389 $35.76 Acquired 11578 Direct
2015-11-02 Common Stock M 328 $46.50 Acquired 11906 Direct
2015-11-02 Common Stock M 328 $60.22 Acquired 12234 Direct
2015-11-02 Common Stock M 328 $61.40 Acquired 12562 Direct
2015-11-02 Common Stock M 340 $62.105 Acquired 12902 Direct
2015-11-02 Common Stock M 327 $78.11 Acquired 13229 Direct
2015-11-02 Common Stock S 1300 $84.30 Disposed 11929 Direct
2015-11-02 Common Stock S 1640 $85.35 Disposed 10289 Direct
2015-11-02 Common Stock S 100 $86.01 Disposed 10189 Direct
2015-11-02 Common Stock F 869 $86.69 Disposed 9320 Direct
2015-11-03 Common Stock S 798 $85.90 Disposed 8522 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-11-02 Employee Stock Option (Right to Buy) $35.76 M 1389 Disposed 2020-01-28 Common Stock (1389) Direct
2015-11-02 Employee Stock Option (Right to Buy) $46.50 M 328 Disposed 2020-10-28 Common Stock (328) Direct
2015-11-02 Employee Stock Option (Right to Buy) $60.22 M 328 Disposed 2021-01-27 Common Stock (328) Direct
2015-11-02 Employee Stock Option (Right to Buy) $61.40 M 328 Disposed 2021-04-28 Common Stock (328) Direct
2015-11-02 Employee Stock Option (Right to Buy) $62.105 M 340 Disposed 2021-10-24 Common Stock (340) Direct
2015-11-02 Employee Stock Option (Right to Buy) $78.11 M 327 Disposed 2021-08-01 Common Stock (327) Direct

Footnotes

F1: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2015.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.79,
inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.98,
inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units.

F5: One-third of the total number of shares subject to the option vested and became exercisable on the 12-month anniversary of the January 28, 2013 grant date, and 1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 28th day of each month thereafter until fully vested on January 28, 2016.

F6: 1/12th of the total number of shares subject to the options vested or shall vest and became or shall become exercisable each quarter following the October 28, 2013 grant date until fully vested on October 28, 2016.

F7: 1/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the January 27, 2014 date of grant until fully vested on January 27, 2017.

F8: 1/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the April 28, 2014 date of grant until fully vested on April 28, 2017.

F9: 1/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the October 24, 2014 date of grant until fully vested on October 24, 2017.

F10: 1/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the August 1, 2014 date of grant until fully vested on August 1, 2017.